{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-073769","form_type":"8-K","ticker":"LCTX","cik":"0000876343","company_name":"Lineage Cell Therapeutics, Inc.","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.250355+00:00","generated_at":"2026-06-01T04:29:55.149451+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Lineage Cell Therapeutics dismisses Withum, appoints Moss Adams as auditor","bullets":["Audit committee dismissed WithumSmith+Brown effective June 11, 2024.","Engaged Moss Adams as independent auditor for fiscal year ending Dec 31, 2024.","No disagreements or reportable events with former auditor in past two years."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-073769","json":"https://secwatch.observer/filing/0000950170-24-073769.json","markdown":"https://secwatch.observer/filing/0000950170-24-073769.md","text":"https://secwatch.observer/filing/0000950170-24-073769.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/876343/000095017024073769/0000950170-24-073769-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/876343/000095017024073769/lctx-20240614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:29:55.149451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}